Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances)

Current Opinion in Cardiology

Volumn 21, Issue 2, 2006, Pages 120-126

  Kirklin, James K ^a   Holman, William L ^a  

^a Kentucky   (United States)

Author keywords

Axial flow device; Bridge; Heart; Left ventricular assist; Mechanical; Pump; Transplantation; Trials

Indexed keywords

ANTICOAGULANT AGENT;

ARTIFICIAL HEART; ASSISTED CIRCULATION; CLINICAL TRIAL; HEALTH CARE ORGANIZATION; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HUMAN; INFECTION; MEDICAL INSTRUMENTATION; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; MYOCARDIAL DISEASE; PRIORITY JOURNAL; REVIEW; THROMBUS; TREATMENT OUTCOME; UNITED STATES;

ASSISTED CIRCULATION; CLINICAL TRIALS; EQUIPMENT DESIGN; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART, ARTIFICIAL; HEART-ASSIST DEVICES; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); REGISTRIES; UNITED STATES;

EID: 33748435950     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000210308.64360.8d     Document Type: Review

References (31)

1. Norman J, Brook MI, Cooley D, Klima T, Kahan B, et al. Total support of the circulation of a patient with post-cardiotomy stone-heart syndrome by a partial artificial heart (AL-VAD) for 5 days followed by heart and kidney transplantation. Lancet 1978; 1:1125-1127.
2. Rose E, Gelijns A, Moskowitz A, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345:1435-1443.
3. Lietz K, Miller LW. Will left-ventricular assist device therapy replace heart transplantation in the foreseeable future? Curr Opin Cardiol 2005; 20:132-137. This review article on destination mechanical circulatory support provides a detailed update on the results and implications of the REMATCH trial and current developments in destination ventricular assist device therapy.
4. Kirklin JK, Naftel DC, Bourge RC, McGiffin DC, Hill JA, et al. Evolving trends in risk profiles and causes of death after heart transplantation: A 10 year multi-institutional study. J Thorac Cardiovasc Surg 2003; 125:881-890.
5. Jaski BE, Kim JC, Naftel DC, Jarcho J, Costanzo MR, et al. Cardiac Transplant Research Database Group. Cardiac transplant outcome of patients supported on left ventricular assist device vs intravenous inotropic therapy. J Heart Lung Transplant 2001; 20:449-456.
6. Deng MC, Edwards LB, Hertz MI, Rowe AW, Keck BM, et al. Mechanical circulatory support device database of the international society for heart and lung transplantation: Third Annual Report 2005. J Heart Lung Transplant 2005; 24:1182-1187. The International Society for Heart and Lung Transplantation has, for the past 5 years, maintained the only international database for mechanical circulatory support. This third annual report provides important information on outcomes with mechanical circulatory support, both in bridging and destination patients. The risk factor analysis provides insight into the importance of age and comorbidities.
7. Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med 2004; 351:859-867. This landmark study reports an outstanding 79% survival to transplant with the CardioWest total artificial heart, which is the only FDA approved total artificial heart device.
8. McBride LR, Naunheim KS, Fiore AC, Moroney DA, Swartz MT, et al. Clinical experience with 111 Thoratec ventricular assist devices. Ann Thorac Surg 1999; 67:1233-1239.
9. Korfer R, El-Banayosy A, Arusoglu L, Minami K, Korner MM, et al. Single-center experience with the Thoratec ventricular assist device. J Thorac Cardiovasc Surg 2000; 119:596-600.
10. Morales DL, Dibardino DJ, McKenzie ED, Heinle JS, Chang AC, et al. Lessons learned from the first application of the DeBakey VAD Child: an intracorporeal ventricular assist device for children. J Heart Lung Transplant 2005; 24:331-337. This report describes management issues related to the application of a rotary pump as a mechanical circulatory support in a child.
11. Blume ED, Naftel DC, Bastardi HJ, et al. Outcome of children listed for transplant and bridged with ventricular assist devices: a multi-institutional study. J Heart Lung Transplant (Abstract) 2005; 24 (Suppl 2):S75.
12. Barbone A, Holmes JW, Heerdt PM, Andrew HS, Naka Y, et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation 2001; 104:670-675.
13. Bruckner BA, Stenson SJ, Perez-Verdia A, et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 2001; 20:457-464.
14. Baba HA, Grabellus F, August C, et al. Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support. J Heart Lung Transplant 2000; 19:668-674.
15. Khan T, Delgado RM, Radovancenic B, et al. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant 2003; 22:137-146.
16. Nagueh SF, Stetson SJ, Lakkis NM, et al. Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation 2001; 103:1844-1850.
17. Schneider MD, Roberts R, Parker TG. Modulation of cardiac genes by mechanical stress. The oncogene signalling hypothesis. Mol Biol Med 1991; 8:167-183.
18. Feldman AM, Weinberg FO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 1993; 73:184-192.
19. McCarthy PM, Nakatahi S, Vargo R, et al. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 1995; 59:609-613.
20. Torre-Amione G, Stetson SJ, Youker KA, et al. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: A potential mechanism for cardiac recovery. Circulation 1999; 100:1189-1193.
21. Blaxall BC, Tschannen-Moran BM, Milano CA, et al. Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 2003; 41:1096-1106.
22. Uray IP, Connelly JH, Thomazy V, et al. Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart. J Heart Lung Transplant 2002; 21:771-782.
23. Goldstein DJ, Moazami N, Seldomridge JA, et al. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg 1997; 63:971-974.
24. Dipla K, Mattiello JA, Jeevanandam V, et al. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 1998; 97:2316-2322.
25. Farrar DJ, Holman WR, McBridge LR, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002; 21:516-521.
26. McNamara DM, Holubkov R, Starling RC, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001; 103:2254-2259.
27. Dandel M, Weng Y, Siniawski H, et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 2005; 112 (9 Suppl):I37-I45. Important insights are provided on long-term outcome after device explantation in patients with dilated cardiomyopathy.
28. Barton PJ, Felkin LE, Birks FJ, et al. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy. Circulation 2005; 112 (9 Suppl):I46-I50. This article describes genetic markers for recovery following left ventricular assist support and clenbuterol therapy.
29. Muller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997; 96:542-549.
30. Frazier OH, Myers TJ. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 1999; 68:734-741.
31. Schmid C, Tjan TD, Etz C, Schmidt C, Wenzelburger F, et al. First clinical experience with the Incor left ventricular assist device. J Heart Lung Transpl 2005; 24:1188-1194. This case report details the first successful application of the Incor left ventricular assist device, a totally intrapericardial axial flow pump.